In the early 1960s, the Thalidomide drug scare caused thousands of worldwide infant deaths and birth defects from a morning sickness medicine for expectant mothers. The disaster transformed drug regulation systems, and changed the pharmaceutical industry’s understanding of chiral properties: the notion that molecules with otherwise identical properties are in fact mirror images, like your right and left hands. Missouri S&T materials science and engineering doctoral student Meagan Kelso wasn’t even close to being born when the chiral consequences of Thalidomide first became apparent nearly 60 years ago. But the drug industry’s continued efforts to fine-tune how it first identifies and then separates chiral compounds is driving the native Texan’s Ph.D. research.
Read More »Dr. Rainer Glaser, professor of chemistry at the University of Missouri-Columbia, has been named chair of chemistry at Missouri S&T. His appointment begins Aug. 1.
Read More »With an enthusiasm for chemistry that’s hard to miss, and scientific achievements that defy her age, Cholaphan Deeleepojananan, a senior in chemistry at Missouri University of Science and Technology, chose her path while in high school in Nakhon Pathom, Thailand.
Read More »A promising discovery for advanced cancer therapy reveals that the efficiency of drug delivery in DNA nanostructures depends on their shapes, say researchers at Missouri University of Science and Technology and the University of Kansas in a scientific paper published today (March 21, 2018).
Read More »Imagine that every time you tapped out a message on your smartphone, it would create electric power instead of sapping your phone’s battery. That scenario could one day be a reality, according to a researcher at Missouri S&T.
Read More »The third and final phase of Missouri S&T’s Biosciences Complex is included in the list of major construction and renovation projects approved by the University of Missouri System Board of Curators Friday, Nov. 10, 2017.
Read More »Researchers from Missouri S&T and Phelps County Regional Medical Center who received funding from the Ozark Biomedical Initiative (OBI) will present their research as part of the OBI Research Symposium Saturday, Aug. 19.
Read More »For years, Jatin Mehta watched his mother’s health degrade as she dealt with the debilitating effects of type 2 diabetes. When she passed away on March 5, 2016, Mehta dedicated his research to her, and to the millions of others around the world that die from age-associated diseases every year.
Read More »